Bayesian Meta-Analysis of NIRS-Guided Neonatal Resuscitation
Bayesian inference for estimating treatment benefit probabilities from individual patient data.
Project Overview
This project evaluated whether interventions guided by cerebral oxygen saturation monitoring during neonatal stabilization and resuscitation were associated with improved outcomes in preterm infants.
The analysis used individual patient data from randomized studies and applied a Bayesian meta-analysis framework to estimate outcome probabilities, absolute treatment effects, credible intervals, and the posterior probability of treatment benefit.
Context: Clinical research · Medical University of Graz
Role: Bayesian analysis, statistical implementation, posterior inference, visualization, and contribution to manuscript preparation.
Methods: Bayesian Meta-Analysis · Individual Patient Data · Clinical Outcomes · Posterior Inference · Probabilistic Interpretation · Medical Statistics
Problem
Clinical trial results are often interpreted using frequentist significance testing, which can make it difficult to communicate the probability and potential magnitude of a treatment benefit directly.
In this project, the available evidence consisted of individual patient data from randomized studies comparing NIRS-guided neonatal resuscitation with standard care. The main analytical challenge was to estimate whether the probability of survival without cerebral injury was higher in the NIRS-guided group while explicitly representing statistical uncertainty.
A Bayesian analysis was used to translate the available data into posterior distributions, credible intervals, and clinically interpretable probabilities of treatment benefit.
Key challenges
- Binary clinical outcome data
- Limited number of included studies
- Need for interpretable uncertainty quantification
- Estimation of group-specific outcome probabilities
- Translation of treatment effects into posterior probabilities
Approach
The analysis workflow combined individual patient outcome data, Bayesian probability modeling, posterior inference, and probabilistic treatment-effect interpretation.
1. Outcome modeling
The primary outcome was modeled as a binary event. For each treatment group, the probability of observing the clinical outcome was estimated using a binomial likelihood.
2. Bayesian meta-analysis
A Bayesian fixed-effect meta-analysis framework was used to combine the available study data. The model estimated posterior distributions for the outcome probabilities in the standard-care and NIRS-guided groups.
3. Posterior treatment effect
The absolute treatment effect was defined as the difference between the posterior outcome probabilities of the NIRS-guided and standard-care groups.
For the beneficial primary outcome, positive values of Δ indicate a higher probability of survival without cerebral injury in the NIRS-guided group.
4. Probability of treatment benefit
The posterior distribution of the treatment effect was used to quantify the probability that the intervention was beneficial. This allowed the results to be expressed as a probability of treatment benefit rather than only as a binary significant / non-significant conclusion.
Figures
Figure 1: Bayesian workflow for estimating treatment benefit from individual patient data across included studies. Patient-level binary outcomes are aggregated into event counts per study and treatment group and modeled using binomial likelihoods with weakly informative priors. Posterior inference yields group-specific outcome probability distributions, from which the absolute treatment effect and the probability of treatment benefit are derived.
Figure 2: Posterior outcome probabilities and absolute treatment effect. (a) Posterior distributions of the probability of survival without cerebral injury for the standard-care and NIRS-guided groups. (b) Posterior distribution of the absolute treatment effect, defined as Δ = p(NIRS-guided) − p(standard care). For this beneficial outcome, positive values indicate a higher outcome probability in the NIRS-guided group and correspond to the posterior probability of treatment benefit, while negative values indicate a lower outcome probability.
Figure 1: Bayesian workflow for estimating treatment benefit from individual patient data across included studies. Patient-level binary outcomes are aggregated into event counts per study and treatment group and modeled using binomial likelihoods with weakly informative priors. Posterior inference yields group-specific outcome probability distributions, from which the absolute treatment effect and the probability of treatment benefit are derived.
Figure 2: Posterior outcome probabilities and absolute treatment effect. (a) Posterior distributions of the probability of survival without cerebral injury for the standard-care and NIRS-guided groups. (b) Posterior distribution of the absolute treatment effect, defined as Δ = p(NIRS-guided) − p(standard care). For this beneficial outcome, positive values indicate a higher outcome probability in the NIRS-guided group and correspond to the posterior probability of treatment benefit, while negative values indicate a lower outcome probability.
Outcome
The project demonstrated how Bayesian analysis can support the interpretation of clinical trial evidence by estimating outcome probabilities, uncertainty intervals, and the probability of treatment benefit directly.
Instead of relying only on whether a treatment effect reaches statistical significance, the Bayesian framework provided a probabilistic interpretation of the intervention effect. This enabled a more intuitive representation of uncertainty and helped translate individual patient data into clinically interpretable evidence.
The workflow illustrates how Bayesian inference can be used in clinical research settings where effect sizes, uncertainty, and the probability of benefit are more informative than a binary significant / non-significant conclusion.
- Bayesian modeling of binary clinical outcome data
- Posterior distributions for group-specific outcome probabilities
- Absolute treatment effect expressed as a probability difference
- Credible intervals and posterior probability of treatment benefit
- Clinically interpretable uncertainty representation for meta-analytic evidence
Related Services
Modeling & Inference →
Probabilistic modeling, posterior inference, and uncertainty-aware interpretation of estimated quantities and treatment effects.
Statistical Analysis →
Bayesian and frequentist statistical analysis of technical, scientific, and clinical data, including uncertainty evaluation and treatment-effect interpretation.
Scientific Support →
Structured presentation of statistical methods, result interpretation, figures, and method descriptions for manuscripts and research reports.
Working with clinical or scientific study data?
Get in touch to discuss how TS-Analytics can support Bayesian analysis, statistical modeling, uncertainty evaluation, or reproducible analysis workflows.
Free initial call · NDA possible · Remote collaboration across AT/DE/EU